Precision BioSciences Inc. - DTIL Company Short-Term Debt

Graphic logo of Precision BioSciences, Inc. (DTIL)

Amidst the fierce competition for gene therapy safety, the current volume of short-term loans demonstrates the financial dynamics of Precision BioSciences (DTIL), where the current amount stands at 0.00. Revenue growth is expected from the implementation of the ARCUS system for treating hereditary pathologies. However, the lack of profitable products and negative cash flow leave the company dependent on partner payments.

DTIL: Precision BioSciences Inc. Short-Term Debt 07/04/2022 - 10/28/2026

Precision BioSciences Inc. - analytical breakdowns and key metrics (DTIL)

- price and consensus price forecast:
Price Chart Precision BioSciences, Inc.|DTIL - Forecast Levels Chart
- market capitalization data:
Market Value Precision BioSciences, Inc.|DTIL - Value Adjusted for Debt and Cash
- book capitalization data:
Book Value per Share Precision BioSciences|DTIL - Total Stockholders' Equity|Market Capitalization to Book Value Ratio precisionbiosciences.com|DTIL - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Precision BioSciences|DTIL - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Precision BioSciences|DTIL - Company Total Debt Obligations|Debts to Book Capitalization Precision BioSciences, Inc.|DTIL - Long-Term Debt Volume|Company Short-Term Debt Precision BioSciences
Analysis of all company metrics:Precision BioSciences, Inc. DTIL
Product sample of Precision BioSciences

Short-term debts measure the volume of obligations maturing within one year, determining liquidity resilience and default risk during external shocks. By analyzing the history of short-term liabilities at Precision BioSciences (DTIL), an investor can assess the company's ability to fund the development of the ARCUS platform and compete with CRISPR technologies without sacrificing financial stability for technological superiority in gene editing.

Competitor analysis for Precision BioSciences

Company Short-Term Debt Tempus AI, Inc|QGEN: Current Liabilities|Company Short-Term Debt Ionis Pharma IONS|Repligen Inc. (RGEN) - Company Short-Term Loans and Borrowings|Company Short-Term Debts RNA (Avidity Biosciences)|Short-Term Debt crisprtx.com|Company Short-Term Debts WGS (GeneDx)|Company Current Liabilities Ultragenyx Pharmaceutical Inc. (RARE)|Company Short-Term Debts BEAM|Sarepta Corp - Short-Term Debt Volume|Company Short-Term Debt TWST (Twist Bioscience)|TXG - Short-Term Debt Volume|Intellia Therapeutics, Inc. - Company Short-Term Debts|STOK (Stoke Therapeutics Inc) - Short-Term Debt Volume|Company Short-Term Debt BLFS (BioLife Corp)|Short-Term Debt WVE|Company Short-Term Debt Maze Therapeutics Inc MAZE|Company Short-Term Indebtedness sionnatx.com SION|Company Current Liabilities Prime Medicine|Company Short-Term Loans and Borrowings Taysha Gene Therapies Inc TSHA|QURE - Company Short-Term Debts|MGTX - Company Short-Term Debt|REGENXBIO Inc. - Company Short-Term Debts|SLDB (solidbio.com) - Short-Term Debt Volume|Company Short-Term Debt OCGN (Ocugen)|Short-Term Debt PACB|BNTC (Benitec) - Company Short-Term Debt|Short-Term Debt Volume Design Corp (DSGN)|Rocket Pharmaceuticals - Company Short-Term Debts|Company Current Liabilities 4dmoleculartherapeutics.com FDMT|Company Short-Term Debts LXEO (Lexeo)|KRRO - Short-Term Debt Volume|Company Short-Term Debts EDIT|SLN (Silence Therapeutics Corp) - Short-Term Debt|Company Short-Term Debt ProQR (PRQR)|Company Short-Term Indebtedness Codexis Bio|Company Short-Term Debts SGMO (Sangamo Therapeutics, Inc.)|Company Current Liabilities nautilus.bio (NAUT)|MGX: Company Short-Term Debts|Generation Bio Co - Short-Term Debt|Company Short-Term Debt BOLD (Boundless Bio, Inc.)|XCUR - Short-Term Debt Volume|Company Short-Term Debts imunon.com|Company Short-Term Indebtedness Phio Pharmaceuticals Corp.|Mustang Bio Inc (MBIO) - Company Current Liabilities|Amount of Current Liabilities TransCode|BNGO (Bionano Genomics, Inc.) - Company Short-Term Debts|Short-Term Debt Volume APDN (adnas.com)|Company Short-Term Debt bluebird bio BLUE|Company Short-Term Debt ImmunoPrecise Antibodies Ltd IPA|Omega (OMGA) - Company Short-Term Debts|OMIC: Company Short-Term Indebtedness|Company Short-Term Debt Regulus Therapeutics|syros.com (SYRS) - Company Short-Term Indebtedness|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Debts TCON|UBX - Company Short-Term Debt